Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: ValuEngine, Inc.
$49.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

MiMedx Group Inc Reaffirms FY 2013, 2014 Revenue Guidance


Wednesday, 4 Sep 2013 03:31pm EDT 

MiMedx Group Inc reiterated its expected revenue range for fiscal 2013 of $54 million to $60 million and its fiscal 2014 goal of $90 million to $110 million. to I/B/E/S Estimates, analysts are expecting the Company to report revenues of $58 million for fiscal 2013 and revenue of $100 million for fiscal 2014. 

Company Quote

11.105
-1.305 -10.52%
23 Jul 2015